Stock CCO THE CALMER CO INTERNATIONAL LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials The Calmer Co International Limited

Equities

CCO

AU0000275216

Pharmaceuticals

Delayed Australian S.E.
Other stock markets
 08:02:29 2024-07-15 pm EDT 		5-day change 1st Jan Change
0.008 AUD 0.00% Intraday chart for The Calmer Co International Limited 0.00% +14.29%
Jul. 03 The Calmer Co International Grows eCommerce Sales in June; Shares Jump 25% MT
Jun. 05 The Calmer Co International Posts 28% Growth in May Revenue; E-commerce Sales Surge 45% MT

Valuation

Fiscal Period: June 2019 2023 2024 2025 2026
Capitalization 1 5.578 1.424 16.34 - -
Enterprise Value (EV) 1 5.578 1.424 16.34 16.34 16.34
P/E ratio - -0.19 x - - -
Yield - - - - -
Capitalization / Revenue 35.1 x - 5.29 x 2.79 x 1.5 x
EV / Revenue 35.1 x - 5.29 x 2.79 x 1.5 x
EV / EBITDA -3.29 x - -5.23 x -9.29 x 167 x
EV / FCF -2,143,250 x - - - -
FCF Yield -0% - - - -
Price to Book - - - - -
Nbr of stocks (in thousands) 69,720 474,778 2,042,526 - -
Reference price 2 0.0800 0.002999 0.008000 0.008000 0.008000
Announcement Date 8/30/19 8/31/23 - - -
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2019 2023 2024 2025 2026
Net sales 1 0.1591 - 3.086 5.861 10.88
EBITDA 1 -1.696 - -3.126 -1.758 0.0979
EBIT 1 -1.724 - -3.968 -2.615 -0.8362
Operating Margin -1,083.63% - -128.58% -44.61% -7.68%
Earnings before Tax (EBT) - - - - -
Net income - -5.242 - - -
Net margin - - - - -
EPS - -0.0162 - - -
Free Cash Flow -2.602 - - - -
FCF margin -1,635.58% - - - -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 8/30/19 8/31/23 - - -
1AUD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: June 2019 2023 2024 2025 2026
Net Debt - - - - -
Net Cash position - - - - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow -2.6 - - - -
ROE (net income / shareholders' equity) -125% - - - -
ROA (Net income/ Total Assets) - - - - -
Assets - - - - -
Book Value Per Share - - - - -
Cash Flow per Share - - - - -
Capex 0.41 - - - -
Capex / Sales 254.99% - - - -
Announcement Date 8/30/19 8/31/23 - - -
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

1st Jan change Capi.
THE CALMER CO INTERNATIONAL LIMITED Stock The Calmer Co International Limited
+14.29% 11.1M
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+13.97% 4.95B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-32.08% 3.6B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
-1.63% 3.03B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-24.62% 2.66B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-9.82% 2.34B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+38.87% 1.85B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD Stock Zhejiang Jolly Pharmaceutical Co.,LTD
+38.84% 1.45B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
-15.47% 1.41B
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK Stock PT Industri Jamu dan Farmasi Sido Muncul Tbk
+40.95% 1.38B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. CCO Stock
  4. Financials The Calmer Co International Limited